Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Laura Scarcella"'
Autor:
Emidio Scarpellini, Laura Scarcella, Giorgio Romanelli, Martina Basilico, Emiliano Lattanzi, Carlo Rasetti, Ludovico Abenavoli, Pierangelo Santori
Publikováno v:
Gastroenterology Insights, Vol 12, Iss 2, Pp 259-269 (2021)
Background: Gut microbiota is a complex ecosystem of bacteria, viruses, archaea, protozoa and yeasts in our intestine. It has several functions, including maintaining human body equilibrium. Microbial “dysbiosis” can be responsible for outbreak o
Externí odkaz:
https://doaj.org/article/1f72237fa5b741468581ff75f8027347
Autor:
Ludovico Abenavoli, Valentina Maurizi, Luigi Boccuto, Arianna Di Berardino, Nena Giostra, Pierangelo Santori, Maria Laura Scarcella, Anna Caterina Procopio, Carlo Rasetti, Emidio Scarpellini
Publikováno v:
Diseases, Vol 10, Iss 4, p 108 (2022)
Acute liver failure (ALF) presents with an acute abnormality of liver blood tests in an individual without underlying chronic liver disease. The clinical course leads to the development of coagulopathy and hepatic encephalopathy. The role of nutritio
Externí odkaz:
https://doaj.org/article/968ff8095a564cd39ff9b87a9c10a1d9
Autor:
Martina Basilico, Emidio Scarpellini, Carlo Rasetti, Giorgio Romanelli, Emiliano Lattanzi, Laura Scarcella, Ludovico Abenavoli, Pierangelo Santori
Publikováno v:
Gastroenterology Insights, Vol 12, Iss 22, Pp 259-269 (2021)
Background: Gut microbiota is a complex ecosystem of bacteria, viruses, archaea, protozoa and yeasts in our intestine. It has several functions, including maintaining human body equilibrium. Microbial “dysbiosis” can be responsible for outbreak o
Autor:
Giuseppe Stipa, Letizia Mazzini, Angelo L. Vescovi, Maurizio Gelati, Lorenzina Bolli, Maria Laura Scarcella, Sandro Carletti, Cristina Spera, Alessandro di Chirico, Domenica Frondizzi, Rossella Rispoli
Publikováno v:
Global Spine Journal. 6:s-0036
IntroductionAmiotrophic lateral sclerosis (ALS) is a neurodegenerative disease with a prevalence rate of up to 7.4/100,000 and the overall risk of developing ALS over a lifetime is 1:400. Most patients die from respiratory failure following a course